CSOP SK Hynix Daily (2x) Leveraged Product(07709.HK) Fell 15.30% to 88.940
Newtimespace News, as of 13:24 on May 14, CSOP SK Hynix Daily (2x) Leveraged Product(07709.HK) was quoted at HKD 88.940, down 15.30%. The product opened at HKD 103.800, with a high of HKD 104.000 and a low of HKD 87.900. The latest Net Asset Value (NAV) per unit is HKD 103.023, with a premium rate of 1.92%. The asset size is approximately HKD 56.809 billion.
CSOP SK Hynix Daily (2x) Leveraged Product(07709.HK) is a Leveraged and Inverse Product issued by CSOP Asset Management, primarily tracking the share price performance of the South Korean individual stock SK Hynix. The product employs a synthetic replication strategy using swaps, with the investment objective of providing, before fees and expenses, investment returns equivalent to two times (2x) the daily performance of SK Hynix ordinary shares. SK Hynix is a global leading semiconductor manufacturer holding a core position in the Dynamic Random-Access Memory (DRAM) and NAND flash memory markets. Its share price movement is highly correlated with the global semiconductor industry cycle and the demand for Artificial Intelligence (AI) computing power.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- CHI MER LAND (00978.HK): JV bid of HKD 1.03 billion for Hung Shui Kiu land accepted, constituting discloseable transaction under alternative size test
- TST PROPERTIES & SINO LAND (00247.HK/00083.HK): Consortium bid of HKD 1.03 billion for Hung Shui Kiu land accepted, JVs established for acquisition and development
- BANK OF CHINA (03988.HK): Completes issuance of RMB 20 billion write-down perpetual capital bonds at coupon rate of 1.86%
- CF PHARMTECH (02652.HK): ICF001 expands indications after implied approval from NMPA, covering four indications including pulmonary fibrosis
- TAI SANG LAND(00089.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 48.32 million, turned profitable from a loss YoY